Medicare Enrolled

Dr. Raj Satkunasivam, M.D., FRCSC

Urology Physician · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
6560 FANNIN ST STE 2100, Houston, TX 77030
7134416455
In practice since 2013 (12 years)
NPI: 1134551278 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Satkunasivam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Satkunasivam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Satkunasivam

Dr. Raj Satkunasivam is an urology physician in Houston, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Satkunasivam performed 5,977 Medicare services across 444 unique beneficiaries.

Between the years covered by Open Payments, Dr. Satkunasivam received a total of $19,219 from 35 pharmaceutical and/or device companies across 97 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Satkunasivam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 19% volume in TX $19,219 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,977
Medicare services
Top 19% in TX for urology physician
444
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~498 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
BCG treatment for bladder cancer 5,301 $2 $14
Instillation of anti-cancer drug into bladder 163 $69 $608
Office visit, established patient (20-29 min) 143 $65 $212
Office visit, established patient (10-19 min) 96 $41 $128
Diagnostic exam of bladder and urethra using an endoscope 88 $184 $1,081
New patient office visit, complex (60-74 min) 57 $164 $600
Office visit, established patient (30-39 min) 35 $95 $314
Office visit, established patient, complex (40-54 min) 33 $141 $421
Removal of lymph nodes of both sides of pelvis using an endoscope 17 $262 $4,212
Surgical removal of prostate and surrounding lymph nodes using an endoscope 17 $898 $9,237
Suture suspension of urethra to control leakage using an endoscope 14 $301 $3,906
Bladder ultrasound after voiding 13 $9 $112
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,219
Total received (2018-2024)
Avg $2,746/year across 7 years
Top 12% in TX for urology physician
35
Companies
97
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,745 (55.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,287 (32.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,188 (11.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,699
2023
$4,759
2022
$6,359
2021
$480
2020
$4,261
2019
$266
2018
$396

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$12,662
PFIZER INC.
$4,553
BOSTON SCIENTIFIC CORPORATION
$244
Boston Scientific Corporation
$223
Photocure Inc
$161
Astellas Pharma US Inc
$137
Janssen Products, LP
$100
UroGen Pharma, Inc.
$99
Ferring Pharmaceuticals Inc.
$90
ConvaTec Inc.
$88
180 Medical, Inc.
$85
UROGEN PHARMA, INC.
$81
Tempus AI, Inc
$75
KARL STORZ Endoscopy-America
$68
Myovant Sciences Inc.
$56
Baxter Healthcare
$45
Sumitomo Pharma America, Inc.
$43
Myriad Genetic Laboratories, Inc.
$36
Abbott Laboratories
$34
Rochester Medical Corporation
$31
AbbVie, Inc.
$30
PROCEPT BioRobotics Corporation
$26
Endo Pharmaceuticals Inc.
$26
ABBVIE INC.
$25
Axonics, Inc.
$25
ABC Home Medical Supply, Inc.
$24
Novo Nordisk Inc
$23
Alafair Biosciences, Inc.
$22
Ethicon US, LLC
$21
Verity Pharmaceuticals Inc.
$20
Acerus Pharmaceuticals Corporation
$16
BioTissue Holdings, Inc.
$15
UROVANT SCIENCES INC
$14
Bayer HealthCare Pharmaceuticals Inc.
$12
J&R Medical, LLC
$12
Top 3 companies account for 90.8% of total payments
Associated products mentioned in payments ›
24/26 FR. · ADSTILADRIN · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · Axium INS DRG IPG · Axonics · BAVENCIO · BIPOLAR · BRACANALYSIS CDX · BRACAnalysis CDx · CATHETER · CUTTING LOOP · Cysview · DA VINCI SP · Da Vinci Surgical System · ESTEEM+ · Enseal X1 · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL FEMALE SUI · GENERAL KIDNEY STONE DISEASE · GENERAL THERAPIES · GENERAL ERECTILE DYSFUNCTION · GENTLECATH · GREENLIGHT · JELMYTO · LUPRON DEPOT · Lupron · Lupron Depot · Myrbetriq · NEOX · Natesto · Nubeqa · ORGOVYX · PERCLOT · REZUM · Rivfloza · Tlando · VersaWrap · XIAFLEX · XTANDI · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $322 per 100 Medicare services performed
Looking for an urology physician in Houston?
Compare urology physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
198
Per 100K population
4.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Satkunasivam is a mixed practice specialist, with above-average Medicare volume (top 19% in TX), with speaking/promotional industry engagement in the top 12% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Satkunasivam experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Satkunasivam performed 5,301 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Satkunasivam receive payments from pharmaceutical companies?
Yes. Dr. Satkunasivam received a total of $19,219 from 35 companies across 97 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Satkunasivam's costs compare to other urology physicians in Houston?
Dr. Satkunasivam's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Satkunasivam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →